GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Erech Finance Cahalacha Ltd (XTAE:EFNC-M) » Definitions » Gross-Profit-to-Asset %

Erech Finance Cahalacha (XTAE:EFNC-M) Gross-Profit-to-Asset % : -7.61% (As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Erech Finance Cahalacha Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Erech Finance Cahalacha's annualized Gross Profit for the quarter that ended in Dec. 2024 was ₪-1.39 Mil. Erech Finance Cahalacha's average Total Assets over the quarter that ended in Dec. 2024 was ₪18.31 Mil. Therefore, Erech Finance Cahalacha's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was -7.61%.


Erech Finance Cahalacha Gross-Profit-to-Asset % Historical Data

The historical data trend for Erech Finance Cahalacha's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Erech Finance Cahalacha Gross-Profit-to-Asset % Chart

Erech Finance Cahalacha Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.58 11.42 7.51 -4.01 -6.94

Erech Finance Cahalacha Semi-Annual Data
Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.70 -3.67 -4.45 -6.42 -7.61

Competitive Comparison of Erech Finance Cahalacha's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Erech Finance Cahalacha's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Erech Finance Cahalacha's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Erech Finance Cahalacha's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Erech Finance Cahalacha's Gross-Profit-to-Asset % falls into.


;
;

Erech Finance Cahalacha Gross-Profit-to-Asset % Calculation

Erech Finance Cahalacha's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=-1.393/( (23.472+16.698)/ 2 )
=-1.393/20.085
=-6.94 %

Erech Finance Cahalacha's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=-1.394/( (19.918+16.698)/ 2 )
=-1.394/18.308
=-7.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Erech Finance Cahalacha Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Erech Finance Cahalacha's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Erech Finance Cahalacha Business Description

Traded in Other Exchanges
N/A
Address
Yakov Eliav 5, Downtown, Jerusalem, ISR
Erech Finance Cahalacha Ltd, formerly Insuline Medical Ltd is a medical device company. It develops & markets technologies to the clinical effectiveness of devices & drugs for the treatment of diabetes. Its products include the InsuPatch device for insulin pump users, & the InsuPad device for injection users. The InsuPad is a company's flagship product.

Erech Finance Cahalacha Headlines

No Headlines